Helen M. Boudreau

Helen is a retired senior executive with a 30-year career in the biotech, pharmaceutical, consulting, and banking industries. Most recently, Helen served as Chief Operating Officer of the Bill & Melinda Gates Medical Research Institute, a non-profit biotech. Over the course of her career, she held positions of increasing scope and responsibility in finance in the biotech and pharmaceutical industries, including Chief Financial Officer of Proteostasis Therapeutics, Chief Financial Officer of FORMA Therapeutics, Chief Financial Officer of Novartis Corporation US, and Chief Financial Officer Global Oncology, Novartis. Prior to Novartis, Helen held positions of increasing responsibility in strategy and finance at Pfizer Inc., including Vice President Finance Customer Business Unit and Commercial Operations and Vice President Finance, Pfizer Global Research and Development. Helen worked earlier in her career at PepsiCo Inc./YUM! Brands, Inc., McKinsey & Company, and Bank of America Corporation. She currently serves as a board member of Premier, Inc., Shattuck Labs Inc., and Field Trip Health Ltd. Helen previously served on the Board of Directors of Evaxion Biotech A/S and Proteostasis Therapeutics, Inc.

Helen earned a B.A. in economics from the University of Maryland, where she graduated summa cum laude, and an M.B.A. from the Darden Graduate School of Business at the University of Virginia.